{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:32Z","timestamp":1787032892443,"version":"build-2736575974"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"DOI":"10.7759\/cureus.93259","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:40:15Z","timestamp":1758883215000},"source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Commonly Used Medications on Erectile Dysfunction: Which Drugs Deserve Particular Attention?"],"prefix":"10.7759","author":[{"given":"Bartosz","family":"Czyzewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Czyzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Dorota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Dorota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zywiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezary","family":"Milczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mariankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illia","family":"Koval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510010089036","article-title":"NIH Consensus Development Panel on Impotence","volume":"270","year":"1993","unstructured":"NIH Consensus Development Panel on Impotence. JAMA. 1993, 270.83-90. 10.1001\/jama.1993.03510010089036","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2017.09.007","article-title":"Relationship of blood pressure and erectile dysfunction in men without previously diagnosed hypertension","volume":"14","author":"Heikkil\u00e4 A","year":"2017","unstructured":"Heikkil\u00e4 A, Kaipia A, Venermo M, Kautiainen H, Korhonen P. Relationship of blood pressure and erectile dysfunction in men without previously diagnosed hypertension. J Sex Med. 2017, 14:1336-41. 10.1016\/j.jsxm.2017.09.007","journal-title":"J Sex Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.10.021","article-title":"Erectile dysfunction in the cardiology practice\u2014a patients' perspective","volume":"167","author":"Nicolai MP","year":"2014","unstructured":"Nicolai MP, van Bavel J, Somsen GA, et al.. Erectile dysfunction in the cardiology practice\u2014a patients' perspective. Am Heart J. 2014, 167:178-85. 10.1016\/j.ahj.2013.10.021","journal-title":"Am Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302305","article-title":"Sexual problems in elderly male and female patients with heart failure","volume":"98","author":"Hoekstra T","year":"2012","unstructured":"Hoekstra T, Lesman-Leegte I, Luttik ML, Sanderman R, van Veldhuisen DJ, Jaarsma T. Sexual problems in elderly male and female patients with heart failure. Heart. 2012, 98:1647-52. 10.1136\/heartjnl-2012-302305","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00589-1","article-title":"A prospective study of risk factors for erectile dysfunction","volume":"176","author":"Bacon CG","year":"2006","unstructured":"Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006, 176:217-21. 10.1016\/S0022-5347(06)00589-1","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.2.213","article-title":"The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease","volume":"166","author":"Grover SA","year":"2006","unstructured":"Grover SA, Lowensteyn I, Kaouache M, et al.. The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006, 166:213-9. 10.1001\/archinte.166.2.213","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1253\/circj.67.656","article-title":"Men's Health Study: Epidemiology of erectile dysfunction and cardiovascular disease","volume":"67","author":"Sasayama S","year":"2003","unstructured":"Sasayama S, Ishii N, Ishikura F, et al.. Men's Health Study: Epidemiology of erectile dysfunction and cardiovascular disease. Circ J. 2003, 67:656-9. 10.1253\/circj.67.656","journal-title":"Circ J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-003-0028-9","article-title":"Erectile dysfunction in the cardiac patient","volume":"4","author":"Kloner RA","year":"2003","unstructured":"Kloner RA. Erectile dysfunction in the cardiac patient. Curr Urol Rep. 2003, 4:466-71. 10.1007\/s11934-003-0028-9","journal-title":"Curr Urol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100096","article-title":"Ficus plants in the co-management of hypertension and erectile dysfunction","volume":"1","author":"Ajeigbe OF","year":"2021","unstructured":"Ajeigbe OF, Oboh G, Ademosun AO. Ficus plants in the co-management of hypertension and erectile dysfunction. Phytomed Plus. 2021, 1:100096. 10.1016\/j.phyplu.2021.100096","journal-title":"Phytomed Plus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1756287216685027","article-title":"Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction","volume":"9","author":"Sharp RP","year":"2017","unstructured":"Sharp RP, Gales BJ. Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction. Ther Adv Urol. 2017, 9:59-63. 10.1177\/1756287216685027","journal-title":"Ther Adv Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(00)00009-2","article-title":"Platelets, oxidant stress and erectile dysfunction: An hypothesis","volume":"46","author":"Jeremy JY","year":"2000","unstructured":"Jeremy JY, Angelini GD, Khan M, et al.. Platelets, oxidant stress and erectile dysfunction: An hypothesis. Cardiovasc Res. 2000, 46:50-4. 10.1016\/s0008-6363(00)00009-2","journal-title":"Cardiovasc Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.05136","article-title":"Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction","volume":"27","author":"Agarwal A","year":"2006","unstructured":"Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl. 2006, 27:335-47. 10.2164\/jandrol.05136","journal-title":"J Androl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0000000000000189","article-title":"Antihypertensive therapy causes erectile dysfunction","volume":"30","author":"Chrysant SG","year":"2015","unstructured":"Chrysant SG. Antihypertensive therapy causes erectile dysfunction. Curr Opin Cardiol. 2015, 30:383-90. 10.1097\/HCO.0000000000000189","journal-title":"Curr Opin Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.oa.16-00242","article-title":"The comparison of the effects of nebivolol and metoprolol on erectile dysfunction in the cases with coronary artery bypass surgery","volume":"23","author":"G\u00fcr \u00d6","year":"2017","unstructured":"G\u00fcr \u00d6, Gurkan S, Yumun G, Turker P. The comparison of the effects of nebivolol and metoprolol on erectile dysfunction in the cases with coronary artery bypass surgery. Ann Thorac Cardiovasc Surg. 2017, 23:91-5. 10.5761\/atcs.oa.16-00242","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002382","article-title":"Update of the position paper on arterial hypertension and erectile dysfunction","volume":"38","author":"Viigimaa M","year":"2020","unstructured":"Viigimaa M, Vlachopoulos C, Doumas M, et al.. Update of the position paper on arterial hypertension and erectile dysfunction. J Hypertens. 2020, 38:1220-34. 10.1097\/HJH.0000000000002382","journal-title":"J Hypertens"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067423","article-title":"A study of sexuality and health among older adults in the United States","volume":"357","author":"Lindau ST","year":"2007","unstructured":"Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007, 357:762-74. 10.1056\/NEJMoa067423","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0524","article-title":"Sexuality among middle-aged and older adults with diagnosed and undiagnosed diabetes: A national, population-based study","volume":"33","author":"Lindau ST","year":"2010","unstructured":"Lindau ST, Tang H, Gomero A, et al.. Sexuality among middle-aged and older adults with diagnosed and undiagnosed diabetes: A national, population-based study. Diabetes Care. 2010, 33:2202-10. 10.2337\/dc10-0524","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.2.207","article-title":"Predictors and prevalence of erectile dysfunction in a racially diverse population","volume":"166","author":"Saigal CS","year":"2006","unstructured":"Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006, 166:207-12. 10.1001\/archinte.166.2.207","journal-title":"Arch Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2019.02.006","article-title":"Erectile dysfunction","volume":"46","author":"Irwin GM","year":"2019","unstructured":"Irwin GM. Erectile dysfunction. Prim Care. 2019, 46:249-55. 10.1016\/j.pop.2019.02.006","journal-title":"Prim Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s3796","article-title":"Selective adherence to antihypertensive medications as a patient-driven means to preserving sexual potency","volume":"2","author":"Voils CI","year":"2008","unstructured":"Voils CI, Sandelowski M, Dahm P, Blouin R, Bosworth HB, Oddone EZ, Steinhauser KE. Selective adherence to antihypertensive medications as a patient-driven means to preserving sexual potency. Patient Prefer Adherence. 2008, 2:201-6. 10.2147\/ppa.s3796","journal-title":"Patient Prefer Adherence"},{"key":"ref21","article-title":"Drug-related erectile dysfunction","volume":"18","author":"Keene LC","year":"1999","unstructured":"Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev. 1999, 18:5-24.","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.07.009","article-title":"Erectile dysfunction and adherence to antihypertensive therapy: Focus on \u03b2-blockers","volume":"81","author":"Manolis A","year":"2020","unstructured":"Manolis A, Doumas M, Ferri C, Mancia G. Erectile dysfunction and adherence to antihypertensive therapy: Focus on \u03b2-blockers. Eur J Intern Med. 2020, 81:1-6. 10.1016\/j.ejim.2020.07.009","journal-title":"Eur J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4081\/aiua.2018.1.44","article-title":"Erectile dysfunction in patients taking psychotropic drugs and treated with phosphodiesterase-5 inhibitors","volume":"90","author":"Mazzilli R","year":"2018","unstructured":"Mazzilli R, Angeletti G, Olana S, et al.. Erectile dysfunction in patients taking psychotropic drugs and treated with phosphodiesterase-5 inhibitors. Arch Ital Urol Androl. 2018, 90:44-8. 10.4081\/aiua.2018.1.44","journal-title":"Arch Ital Urol Androl"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)90272-1","article-title":"Apomorphine-induced penile erection and yawning: Site of action in brain","volume":"415","author":"Melis MR","year":"1987","unstructured":"Melis MR, Argiolas A, Gessa GL. Apomorphine-induced penile erection and yawning: Site of action in brain. Brain Res. 1987, 415:98-104. 10.1016\/0006-8993(87)90272-1","journal-title":"Brain Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00843.x","article-title":"The effects of citalopram and fluoxetine on sexual behavior in healthy men: Evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study","volume":"5","author":"Madeo B","year":"2008","unstructured":"Madeo B, Bettica P, Milleri S, Balestrieri A, Granata AR, Carani C, Rochira V. The effects of citalopram and fluoxetine on sexual behavior in healthy men: Evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med. 2008, 5:2431-41. 10.1111\/j.1743-6109.2008.00843.x","journal-title":"J Sex Med"},{"key":"ref26","article-title":"Major depressive disorder, antidepressants, and sexual dysfunction","volume":"67","author":"Clayton AH","year":"2006","unstructured":"Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry. 2006, 67:33-7.","journal-title":"J Clin Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.10.004","article-title":"Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?","volume":"121","author":"Bijlsma EY","year":"2014","unstructured":"Bijlsma EY, Chan JS, Olivier B, Veening JG, Millan MJ, Waldinger MD, Oosting RS. Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?. Pharmacol Biochem Behav. 2014, 121:88-101. 10.1016\/j.pbb.2013.10.004","journal-title":"Pharmacol Biochem Behav"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00013","article-title":"Effects of SSRIs on sexual function: A critical review","volume":"19","author":"Rosen RC","year":"1999","unstructured":"Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol. 1999, 19:67-85. 10.1097\/00004714-199902000-00013","journal-title":"J Clin Psychopharmacol"},{"key":"ref29","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction","volume":"62","author":"Montejo AL","year":"2001","unstructured":"Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001, 62:10-21.","journal-title":"J Clin Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00520.x","article-title":"Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder","volume":"4","author":"Clayton A","year":"2007","unstructured":"Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med. 2007, 4:917-29. 10.1111\/j.1743-6109.2007.00520.x","journal-title":"J Sex Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.11.003","article-title":"Antidepressant-induced sexual dysfunction in men","volume":"121","author":"Segraves RT","year":"2014","unstructured":"Segraves RT, Balon R. Antidepressant-induced sexual dysfunction in men. Pharmacol Biochem Behav. 2014, 121:132-7. 10.1016\/j.pbb.2013.11.003","journal-title":"Pharmacol Biochem Behav"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12231","article-title":"Common prescription medication use and erectile dysfunction: Results from the Boston Area Community Health (BACH) survey","volume":"112","author":"Kupelian V","year":"2013","unstructured":"Kupelian V, Hall SA, McKinlay JB. Common prescription medication use and erectile dysfunction: Results from the Boston Area Community Health (BACH) survey. BJU Int. 2013, 112:1178-87. 10.1111\/bju.12231","journal-title":"BJU Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.03.127","article-title":"The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males","volume":"178","author":"Francis ME","year":"2007","unstructured":"Francis ME, Kusek JW, Nyberg LM, Eggers PW. The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol. 2007, 178:591-6. 10.1016\/j.juro.2007.03.127","journal-title":"J Urol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000198","article-title":"Sexual side-effects of antidepressant and antipsychotic drugs","volume":"28","author":"Montejo AL","year":"2015","unstructured":"Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015, 28:418-23. 10.1097\/YCO.0000000000000198","journal-title":"Curr Opin Psychiatry"},{"key":"ref35","article-title":"Antidepressant-related erectile dysfunction: Management via avoidance, switching antidepressants, antidotes, and adaptation","volume":"64","author":"Labbate LA","year":"2003","unstructured":"Labbate LA, Croft HA, Oleshansky MA. Antidepressant-related erectile dysfunction: Management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry. 2003, 64:11-9.","journal-title":"J Clin Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.androl.2019.08.003","article-title":"Benzodiazepines related sexual dysfunctions: A critical review on pharmacology and mechanism of action. (Article in Spanish)","volume":"19","author":"Hosseinzadeh Zoroufchi B","year":"2021","unstructured":"Hosseinzadeh Zoroufchi B, Doustmohammadi H, Mokhtari T, Abdollahpour A. Benzodiazepines related sexual dysfunctions: A critical review on pharmacology and mechanism of action. (Article in Spanish). Rev Int Androl. 2021, 19:62-8. 10.1016\/j.androl.2019.08.003","journal-title":"Rev Int Androl"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.1.50","article-title":"Nithsdale Schizophrenia Surveys 24: Sexual dysfunction. Case-control study","volume":"182","author":"Macdonald S","year":"2003","unstructured":"Macdonald S, Halliday J, MacEW T, Sharkey V, Farrington S, Wall S, McCreadie RG. Nithsdale Schizophrenia Surveys 24: Sexual dysfunction. Case-control study. Br J Psychiatry. 2003, 182:50-6. 10.1192\/bjp.182.1.50","journal-title":"Br J Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003546.pub3","article-title":"Management of sexual dysfunction due to antipsychotic drug therapy","volume":"11","author":"Schmidt HM","year":"2012","unstructured":"Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev. 2012, 11:CD003546. 10.1002\/14651858.CD003546.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-981480","article-title":"Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication","volume":"40","author":"Westheide J","year":"2007","unstructured":"Westheide J, Cohen S, Bender S, et al.. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry. 2007, 40:140-5. 10.1055\/s-2007-981480","journal-title":"Pharmacopsychiatry"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.03.003","article-title":"Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study","volume":"19","author":"Novick D","year":"2009","unstructured":"Novick D, Haro JM, Perrin E, Suarez D, Texeira JM. Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Eur Neuropsychopharmacol. 2009, 19:542-50. 10.1016\/j.euroneuro.2009.03.003","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-017-0166-y","article-title":"Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: Comparison between aripiprazole and other atypical antipsychotics","volume":"16","author":"Kirino E","year":"2017","unstructured":"Kirino E. Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: Comparison between aripiprazole and other atypical antipsychotics. Ann Gen Psychiatry. 2017, 16:43. 10.1186\/s12991-017-0166-y","journal-title":"Ann Gen Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2019.08.022","article-title":"Management of antipsychotic-related sexual dysfunction: Systematic review","volume":"16","author":"Allen K","year":"2019","unstructured":"Allen K, Baban A, Munjiza J, Pappa S. Management of antipsychotic-related sexual dysfunction: Systematic review. J Sex Med. 2019, 16:1978-87. 10.1016\/j.jsxm.2019.08.022","journal-title":"J Sex Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1994.tb05859.x","article-title":"Compliance with antipsychotic drug treatment: Influence of side effects","volume":"382","author":"Fleischhacker WW","year":"1994","unstructured":"Fleischhacker WW, Meise U, G\u00fcnther V, Kurz M. Compliance with antipsychotic drug treatment: Influence of side effects. Acta Psychiatr Scand Suppl. 1994, 382:11-5. 10.1111\/j.1600-0447.1994.tb05859.x","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.181.1.49","article-title":"Sexual dysfunction in patients taking conventional antipsychotic medication","volume":"181","author":"Smith SM","year":"2002","unstructured":"Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry. 2002, 181:49-55. 10.1192\/bjp.181.1.49","journal-title":"Br J Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e328017f6c4","article-title":"Sexual dysfunction in schizophrenia","volume":"20","author":"Malik P","year":"2007","unstructured":"Malik P. Sexual dysfunction in schizophrenia. Curr Opin Psychiatry. 2007, 20:138-42. 10.1097\/YCO.0b013e328017f6c4","journal-title":"Curr Opin Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (Dys)function in schizophrenia: An overview of clinically relevant findings","volume":"41","author":"de Boer MK","year":"2015","unstructured":"de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. The facts about sexual (Dys)function in schizophrenia: An overview of clinically relevant findings. Schizophr Bull. 2015, 41:674-86. 10.1093\/schbul\/sbv001","journal-title":"Schizophr Bull"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s4766","article-title":"Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone","volume":"5","author":"Liu-Seifert H","year":"2009","unstructured":"Liu-Seifert H, Kinon BJ, Tennant CJ, Sniadecki J, Volavka J. Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone. Neuropsychiatr Dis Treat. 2009, 5:47-54. 10.2147\/ndt.s4766","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182199bcc","article-title":"Sexual dysfunction in first-episode schizophrenia patients: Results from European First Episode Schizophrenia Trial","volume":"31","author":"Malik P","year":"2011","unstructured":"Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW. Sexual dysfunction in first-episode schizophrenia patients: Results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol. 2011, 31:274-80. 10.1097\/JCP.0b013e3182199bcc","journal-title":"J Clin Psychopharmacol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti A","year":"2011","unstructured":"Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol. 2011, 26:130-40. 10.1097\/YIC.0b013e328341e434","journal-title":"Int Clin Psychopharmacol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.17392\/1360-21","article-title":"The role of aripiprazole in improvement of penile erection in schizophrenia patients with erectile dysfunction","volume":"18","author":"Handayati Harahap D","year":"2021","unstructured":"Handayati Harahap D, Raymondalexas Marchira C, Nurwening Solikhah E, Moch Rizal D. The role of aripiprazole in improvement of penile erection in schizophrenia patients with erectile dysfunction. Med Glas (Zenica). 2021, 18:432-7. 10.17392\/1360-21","journal-title":"Med Glas (Zenica)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106495","article-title":"Sexual dysfunction in people with epilepsy","volume":"100","author":"Rathore C","year":"2019","unstructured":"Rathore C, Henning OJ, Luef G, Radhakrishnan K. Sexual dysfunction in people with epilepsy. Epilepsy Behav. 2019, 100:106495. 10.1016\/j.yebeh.2019.106495","journal-title":"Epilepsy Behav"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1586\/ern.11.58","article-title":"Sexual and reproductive dysfunction associated with antiepileptic drug use in men with epilepsy","volume":"11","author":"Calabr\u00f2 RS","year":"2011","unstructured":"Calabr\u00f2 RS, Marino S, Bramanti P. Sexual and reproductive dysfunction associated with antiepileptic drug use in men with epilepsy. Expert Rev Neurother. 2011, 11:887-95. 10.1586\/ern.11.58","journal-title":"Expert Rev Neurother"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-3753-5","article-title":"The relationship between epilepsy and sexual dysfunction: A review of the literature","volume":"5","author":"Atif M","year":"2016","unstructured":"Atif M, Sarwar MR, Scahill S. The relationship between epilepsy and sexual dysfunction: A review of the literature. Springerplus. 2016, 5:2070. 10.1186\/s40064-016-3753-5","journal-title":"Springerplus"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.07.018","article-title":"Vasogenic erectile dysfunction Topiramate-induced","volume":"114","author":"Civardi C","year":"2012","unstructured":"Civardi C, Collini A, Gontero P, Monaco F. Vasogenic erectile dysfunction Topiramate-induced. Clin Neurol Neurosurg. 2012, 114:70-1. 10.1016\/j.clineuro.2011.07.018","journal-title":"Clin Neurol Neurosurg"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.11.028","article-title":"Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy","volume":"20","author":"Xiaotian X","year":"2013","unstructured":"Xiaotian X, Hengzhong Z, Yao X, Zhipan Z, Daoliang X, Yumei W. Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy. J Clin Neurosci. 2013, 20:1492-7. 10.1016\/j.jocn.2012.11.028","journal-title":"J Clin Neurosci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2003.12.006","article-title":"Epilepsy and erectile dysfunction: A review","volume":"13","author":"Smaldone M","year":"2004","unstructured":"Smaldone M, Sukkarieh T, Reda A, Khan A. Epilepsy and erectile dysfunction: A review. Seizure. 2004, 13:453-9. 10.1016\/j.seizure.2003.12.006","journal-title":"Seizure"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000492137.63346.75","article-title":"Impact of valsartan and combination of valsartan and hydrochlorothiazide on erectile dysfunction in patients with mild to moderate hypertension","volume":"34","author":"Salobir B","year":"2016","unstructured":"Salobir B, Brguljan-Hitij J, Dolenc P, et al.. Impact of valsartan and combination of valsartan and hydrochlorothiazide on erectile dysfunction in patients with mild to moderate hypertension. J Hypertens. 2016, 34:e275. 10.1097\/01.hjh.0000492137.63346.75","journal-title":"J Hypertens"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.06.013","article-title":"Nebivolol protects erectile functions compared to Metoprolol in hypertensive men with atherogenic, venogenic, psychogenic erectile dysfunction: A prospective, randomized, cross-over, clinical trial","volume":"103","author":"Gungor G","year":"2022","unstructured":"Gungor G, Perk H, Soyupek S, Baykal B, Demir M, Sezer MT. Nebivolol protects erectile functions compared to Metoprolol in hypertensive men with atherogenic, venogenic, psychogenic erectile dysfunction: A prospective, randomized, cross-over, clinical trial. Eur J Intern Med. 2022, 103:69-75. 10.1016\/j.ejim.2022.06.013","journal-title":"Eur J Intern Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2007.04551.x","article-title":"Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): Benefit of nebivolol versus metoprolol in hypertensive men","volume":"34","author":"Brixius K","year":"2007","unstructured":"Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): Benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007, 34:327-31. 10.1111\/j.1440-1681.2007.04551.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v15i4.29","article-title":"Erectile dysfunction: Prevalence, risk factors and involvement of antihypertensive drugs intervention","volume":"15","author":"Salman M","year":"2016","unstructured":"Salman M, Shehzadi N, Khan MT, et al.. Erectile dysfunction: Prevalence, risk factors and involvement of antihypertensive drugs intervention. Trop J Pharm Res. 2016, 15:869-76. 10.4314\/tjpr.v15i4.29","journal-title":"Trop J Pharm Res"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i9.908","article-title":"Management of erectile dysfunction in hypertension: Tips and tricks","volume":"6","author":"Viigimaa M","year":"2014","unstructured":"Viigimaa M, Vlachopoulos C, Lazaridis A, Doumas M. Management of erectile dysfunction in hypertension: Tips and tricks. World J Cardiol. 2014, 6:908-15. 10.4330\/wjc.v6.i9.908","journal-title":"World J Cardiol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01710.x","article-title":"Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling","volume":"7","author":"Angulo J","year":"2010","unstructured":"Angulo J, Wright HM, Cuevas P, et al.. Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling. J Sex Med. 2010, 7:2681-97. 10.1111\/j.1743-6109.2010.01710.x","journal-title":"J Sex Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2009.00123.x","article-title":"Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents","volume":"28","author":"Cordero A","year":"2010","unstructured":"Cordero A, Bertomeu-Mart\u00ednez V, Maz\u00f3n P, F\u00e1cila L, Bertomeu-Gonz\u00e1lez V, Conthe P, Gonz\u00e1lez-Juanatey JR. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther. 2010, 28:15-22. 10.1111\/j.1755-5922.2009.00123.x","journal-title":"Cardiovasc Ther"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04020-x","article-title":"Anti-hypertensive medications and erectile dysfunction: Focus on \u03b2-blockers","volume":"87","author":"Corona G","year":"2025","unstructured":"Corona G, Vena W, Pizzocaro A, Salvio G, Sparano C, Sforza A, Maggi M. Anti-hypertensive medications and erectile dysfunction: Focus on \u03b2-blockers. Endocrine. 2025, 87:11-26. 10.1007\/s12020-024-04020-x","journal-title":"Endocrine"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901516","article-title":"Cardiovascular drug use and the incidence of erectile dysfunction","volume":"19","author":"Shiri R","year":"2007","unstructured":"Shiri R, Koskim\u00e4ki J, H\u00e4kkinen J, Auvinen A, Tammela TL, Hakama M. Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res. 2007, 19:208-12. 10.1038\/sj.ijir.3901516","journal-title":"Int J Impot Res"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7262.2006.00076.x","article-title":"Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients","volume":"8","author":"Doumas M","year":"2006","unstructured":"Doumas M, Tsakiris A, Douma S, et al.. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl. 2006, 8:177-82. 10.1111\/j.1745-7262.2006.00076.x","journal-title":"Asian J Androl"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02563.x","article-title":"Cardiovascular risk, drugs and erectile function--a systematic analysis","volume":"65","author":"Baumh\u00e4kel M","year":"2011","unstructured":"Baumh\u00e4kel M, Schlimmer N, Kratz M, Hackett G, Jackson G, B\u00f6hm M. Cardiovascular risk, drugs and erectile function--a systematic analysis. Int J Clin Pract. 2011, 65:289-98. 10.1111\/j.1742-1241.2010.02563.x","journal-title":"Int J Clin Pract"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.7.676.34571","article-title":"Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort","volume":"21","author":"Derby CA","year":"2001","unstructured":"Derby CA, Barbour MM, Hume AL, McKinlay JB. Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy. 2001, 21:676-83. 10.1592\/phco.21.7.676.34571","journal-title":"Pharmacotherapy"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07197-9","article-title":"Effects of major antihypertensive drug classes on erectile function: A network meta-analysis","volume":"36","author":"Farmakis IT","year":"2022","unstructured":"Farmakis IT, Pyrgidis N, Doundoulakis I, Mykoniatis I, Akrivos E, Giannakoulas G. Effects of major antihypertensive drug classes on erectile function: A network meta-analysis. Cardiovasc Drugs Ther. 2022, 36:903-14. 10.1007\/s10557-021-07197-9","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.29.1.8","article-title":"Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS)","volume":"29","author":"Grimm RH Jr","year":"1997","unstructured":"Grimm RH Jr, Grandits GA, Prineas RJ, et al.. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997, 29:8-14. 10.1161\/01.hyp.29.1.8","journal-title":"Hypertension"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.10.008","article-title":"The 45-year story of the development of an anti-aldosterone more specific than spironolactone","volume":"217","author":"M\u00e9nard J","year":"2004","unstructured":"M\u00e9nard J. The 45-year story of the development of an anti-aldosterone more specific than spironolactone. Mol Cell Endocrinol. 2004, 217:45-52. 10.1016\/j.mce.2003.10.008","journal-title":"Mol Cell Endocrinol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(03)80282-5","article-title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","volume":"25","author":"Burgess ED","year":"2003","unstructured":"Burgess ED, Lacourci\u00e8re Y, Ruilope-Urioste LM, et al.. Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. Clin Ther. 2003, 25:2388-404. 10.1016\/s0149-2918(03)80282-5","journal-title":"Clin Ther"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy HK","year":"2011","unstructured":"Parthasarathy HK, M\u00e9nard J, White WB, et al.. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens. 2011, 29:980-90. 10.1097\/HJH.0b013e3283455ca5","journal-title":"J Hypertens"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(82)90041-x","article-title":"Sexual dysfunction associated with oral antihypertensive medication: A critical survey of the literature","volume":"4","author":"Moss HB","year":"1982","unstructured":"Moss HB, Procci WR. Sexual dysfunction associated with oral antihypertensive medication: A critical survey of the literature. Gen Hosp Psychiatry. 1982, 4:121-9. 10.1016\/0163-8343(82)90041-x","journal-title":"Gen Hosp Psychiatry"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1974.tb03142.x","article-title":"Sexual behaviour patterns in male hypertensives","volume":"4","author":"Laver MC","year":"1974","unstructured":"Laver MC. Sexual behaviour patterns in male hypertensives. Aust N Z J Med. 1974, 4:29-31. 10.1111\/j.1445-5994.1974.tb03142.x","journal-title":"Aust N Z J Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5969.501-a","article-title":"Letter: Side effects of methyldopa","volume":"2","author":"Alexander WD","year":"1975","unstructured":"Alexander WD, Evans JI. Letter: Side effects of methyldopa. Br Med J. 1975, 2:501. 10.1136\/bmj.2.5969.501-a","journal-title":"Br Med J"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.11.092","article-title":"Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction","volume":"185","author":"Gleason JM","year":"2011","unstructured":"Gleason JM, Slezak JM, Jung H, et al.. Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol. 2011, 185:1388-93. 10.1016\/j.juro.2010.11.092","journal-title":"J Urol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)01000-1","article-title":"Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction","volume":"175","author":"Shiri R","year":"2006","unstructured":"Shiri R, Koskimaki J, Hakkinen J, Tammela TL, Auvinen A, Hakama M. Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction. J Urol. 2006, 175:1812-5. 10.1016\/S0022-5347(05)01000-1","journal-title":"J Urol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1329847","article-title":"Potential causal association between aspirin use and erectile dysfunction in European population: A Mendelian randomization study","volume":"14","author":"Li R","year":"2023","unstructured":"Li R, Peng L, Deng D, Li G, Wu S. Potential causal association between aspirin use and erectile dysfunction in European population: A Mendelian randomization study. Front Endocrinol (Lausanne). 2023, 14:1329847. 10.3389\/fendo.2023.1329847","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13264","article-title":"Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: Results from the Prostate Cancer Prevention Trial","volume":"117","author":"Patel DP","year":"2016","unstructured":"Patel DP, Schenk JM, Darke A, Myers JB, Brant WO, Hotaling JM. Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: Results from the Prostate Cancer Prevention Trial. BJU Int. 2016, 117:500-6. 10.1111\/bju.13264","journal-title":"BJU Int"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011367","article-title":"Association between use of aspirin or non-aspirin non-steroidal anti-inflammatory drugs and erectile dysfunction: A systematic review","volume":"97","author":"Li T","year":"2018","unstructured":"Li T, Wu C, Fu F, Qin F, Wei Q, Yuan J. Association between use of aspirin or non-aspirin non-steroidal anti-inflammatory drugs and erectile dysfunction: A systematic review. Medicine. 2018, 97:e11367. 10.1097\/MD.0000000000011367","journal-title":"Medicine"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12108","article-title":"Aspirin for treatment of lithium-associated sexual dysfunction in men: Randomized double-blind placebo-controlled study","volume":"15","author":"Saroukhani S","year":"2013","unstructured":"Saroukhani S, Emami-Parsa M, Modabbernia A, Ashrafi M, Farokhnia M, Hajiaghaee R, Akhondzadeh S. Aspirin for treatment of lithium-associated sexual dysfunction in men: Randomized double-blind placebo-controlled study. Bipolar Disord. 2013, 15:650-6. 10.1111\/bdi.12108","journal-title":"Bipolar Disord"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010171","article-title":"Lithium and erectile dysfunction: An overview","volume":"11","author":"Sheibani M","year":"2022","unstructured":"Sheibani M, Ghasemi M, Dehpour AR. Lithium and erectile dysfunction: An overview. Cells. 2022, 11:171. 10.3390\/cells11010171","journal-title":"Cells"},{"key":"ref84","article-title":"Digoxin therapy for heart failure: An update","volume":"74","author":"Morris SA","year":"2006","unstructured":"Morris SA, Hatcher HF, Reddy DK. Digoxin therapy for heart failure: An update. Am Fam Physician. 2006, 74:613-8.","journal-title":"Am Fam Physician"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1080\/00926238708403879","article-title":"The effect of long-term administration of digoxin on plasma androgens and sexual dysfunction","volume":"13","author":"Neri A","year":"1987","unstructured":"Neri A, Zukerman Z, Aygen M, Lidor Y, Kaufman H. The effect of long-term administration of digoxin on plasma androgens and sexual dysfunction. J Sex Marital Ther. 1987, 13:58-63. 10.1080\/00926238708403879","journal-title":"J Sex Marital Ther"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199805000-00033","article-title":"A possible mechanism for alteration of human erectile function by digoxin: Inhibition of corpus cavernosum sodium\/potassium adenosine triphosphatase activity","volume":"159","author":"Gupta S","year":"1998","unstructured":"Gupta S, Salimpour P, Saenz de Tejada I, et al.. A possible mechanism for alteration of human erectile function by digoxin: Inhibition of corpus cavernosum sodium\/potassium adenosine triphosphatase activity. J Urol. 1998, 159:1529-36. 10.1097\/00005392-199805000-00033","journal-title":"J Urol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2017.08.010","article-title":"Association between opioid use and risk of erectile dysfunction: A systematic review and meta-analysis","volume":"14","author":"Zhao S","year":"2017","unstructured":"Zhao S, Deng T, Luo L, et al.. Association between opioid use and risk of erectile dysfunction: A systematic review and meta-analysis. J Sex Med. 2017, 14:1209-19. 10.1016\/j.jsxm.2017.08.010","journal-title":"J Sex Med"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00707.x","article-title":"Sexual dysfunction in men who abuse illicit drugs: A preliminary report","volume":"6","author":"Bang-Ping J","year":"2009","unstructured":"Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: A preliminary report. J Sex Med. 2009, 6:1072-80. 10.1111\/j.1743-6109.2007.00707.x","journal-title":"J Sex Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n02_08","article-title":"Methadone maintenance and male sexual dysfunction","volume":"24","author":"Brown R","year":"2005","unstructured":"Brown R, Balousek S, Mundt M, Fleming M. Methadone maintenance and male sexual dysfunction. J Addict Dis. 2005, 24:91-106. 10.1300\/J069v24n02_08","journal-title":"J Addict Dis"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2010.509279","article-title":"Erectile dysfunction in opioid users: Lack of association with serum testosterone","volume":"29","author":"Cioe PA","year":"2010","unstructured":"Cioe PA, Friedmann PD, Stein MD. Erectile dysfunction in opioid users: Lack of association with serum testosterone. J Addict Dis. 2010, 29:455-60. 10.1080\/10550887.2010.509279","journal-title":"J Addict Dis"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164046","article-title":"Opioid-induced sexual dysfunction in cancer patients","volume":"14","author":"Salata B","year":"2022","unstructured":"Salata B, Kluczna A, Dzier\u017canowski T. Opioid-induced sexual dysfunction in cancer patients. Cancers. 2022, 14:4046. 10.3390\/cancers14164046","journal-title":"Cancers"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181850df6","article-title":"The impact of opioids on the endocrine system","volume":"25","author":"Katz N","year":"2009","unstructured":"Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009, 25:170-5. 10.1097\/AJP.0b013e3181850df6","journal-title":"Clin J Pain"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.004515","article-title":"Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction","volume":"63","author":"Andersson KE","year":"2011","unstructured":"Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011, 63:811-59. 10.1124\/pr.111.004515","journal-title":"Pharmacol Rev"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-009-0793-9","article-title":"Interactions between morphine and nitric oxide in various organs","volume":"23","author":"Toda N","year":"2009","unstructured":"Toda N, Kishioka S, Hatano Y, Toda H. Interactions between morphine and nitric oxide in various organs. J Anesth. 2009, 23:554-68. 10.1007\/s00540-009-0793-9","journal-title":"J Anesth"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1177\/1557988319892735","article-title":"Angiotensin receptor blockers for erectile dysfunction in hypertensive men: A brief meta-analysis of randomized control trials","volume":"13","author":"Ismail SB","year":"2019","unstructured":"Ismail SB, Noor NM, Hussain NH, Sulaiman Z, Shamsudin MA, Irfan M. Angiotensin receptor blockers for erectile dysfunction in hypertensive men: A brief meta-analysis of randomized control trials. Am J Mens Health. 2019, 13:10.1177\/1557988319892735","journal-title":"Am J Mens Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414019-the-impact-of-commonly-used-medications-on-erectile-dysfunction-which-drugs-deserve-particular-attention","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:40:16Z","timestamp":1758883216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414019-the-impact-of-commonly-used-medications-on-erectile-dysfunction-which-drugs-deserve-particular-attention"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":95,"URL":"https:\/\/doi.org\/10.7759\/cureus.93259","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}